国人和国际“接轨”的速度是很快的。“贵夫人手牵哈巴狗在街头漫步”似乎昨日还是三十年代的影片中的镜头,而今已是现实生活中的“实景”!宠物有助养生,然而,事物都有两面性。有人认为,手牵宠物散步,也是锻炼。本文打消了此种误解:Dog ...国人和国际“接轨”的速度是很快的。“贵夫人手牵哈巴狗在街头漫步”似乎昨日还是三十年代的影片中的镜头,而今已是现实生活中的“实景”!宠物有助养生,然而,事物都有两面性。有人认为,手牵宠物散步,也是锻炼。本文打消了此种误解:Dog owners get less exercise than non-dog owners!本文出现bites一词,此词却不是“咬”的意思(附带说明,上海去年有6万多人被宠物狗咬伤)。另外,本文出现了countrymen一词,它的含义是:同胞;同国人。但是,本文作者却“添足”成:his countrymen and women。请注意语言的变化。作者未必就是女权主义者(feminism)展开更多
When dogs and cats are not retained in a home, they are re-homed to somewhere, and while there is a collection of research around relinquishment to shelters, little is known about the general re-homing picture. A cros...When dogs and cats are not retained in a home, they are re-homed to somewhere, and while there is a collection of research around relinquishment to shelters, little is known about the general re-homing picture. A cross sectional random digit dial survey was conducted with an aim to learn more about who is re-homing, where they are re-homing and why they are re-homing owned dogs and cats in the US. We found the prevalence of re-homing in five years at 6% making for an estimated 6.12 million household re-homing pets every five years. Pets were most likely to be re-homed by being given to a friend or family member (37%) closely followed by being taken to a shelter. Those who re-homed due to a reason related to the pet as opposed to reasons such as family issues were more likely to re-home to a shelter. For respondents who rented, housing reasons were the number one reason for re-homing, and for respondents of lower income, they were significantly more likely to re-home due to cost and housing issues as opposed to pet related issues. We conclude that some reasons for re-homing are not easily modified and humane re-homing is the best option, but that there are many areas in which intervention and prevention programs may increase retention.展开更多
Background: Cimicoxib is a coxib recently licensed in Europe for pain and inflammation associated with osteoarthritis (OA), and the management of perioperative pain due to orthopaedic or soft tissue surgery. Purpose: ...Background: Cimicoxib is a coxib recently licensed in Europe for pain and inflammation associated with osteoarthritis (OA), and the management of perioperative pain due to orthopaedic or soft tissue surgery. Purpose: This prospective study was to complete the product information for the end users by providing additional scientific data obtained after a thirty-day treatment course of cimicoxib in dogs with OA, and to collect owners’ feedback. Data were collected from nine European countries with 492 client owned dogs recruited to the trial. Dogs were treated once daily with 2 mg/kg cimicoxib orally. Immediately before, at Day (D) 15 and D30 after the start of treatment veterinarians and owners scored body condition, appetite, locomotion, lameness, pain on palpation and manipulation of the joint and joint effusion (veterinarians) and dog demeanor and well being (owners). In a subset of dogs, serum urea (n = 191), creatinine (n = 184), AST (n = 141) and ALT (n = 174) were measured at day (D) 0 and D30. Statistical tests were carried out to detect significant changes in the clinical parameters with time. Results and Discussion: Veterinary and owner assessments were analysed from 236 and 215 dogs respectively. Improvements in locomotion, mobility, pain scores and dog demeanor and body condition were identified;outcome measures assessed by veterinarians continued to improve after 15 days of treatment up to the 30-day time point. At D30 a significantly higher number of dogs had an urea concentration superior to the upper limit of the reference range. However, there was no significant difference for creatinine, ALT and AST. Conclusions: A 30-day treatment course with cimicoxib improved locomotion and decreased pain scores in dogs with OA, with minimal adverse effects. These data, support pre-clinical data in dogs receiving cimicoxib and are useful for veterinarians making decisions about which NSAID to administer to dogs that require pain management for OA.展开更多
文摘国人和国际“接轨”的速度是很快的。“贵夫人手牵哈巴狗在街头漫步”似乎昨日还是三十年代的影片中的镜头,而今已是现实生活中的“实景”!宠物有助养生,然而,事物都有两面性。有人认为,手牵宠物散步,也是锻炼。本文打消了此种误解:Dog owners get less exercise than non-dog owners!本文出现bites一词,此词却不是“咬”的意思(附带说明,上海去年有6万多人被宠物狗咬伤)。另外,本文出现了countrymen一词,它的含义是:同胞;同国人。但是,本文作者却“添足”成:his countrymen and women。请注意语言的变化。作者未必就是女权主义者(feminism)
文摘When dogs and cats are not retained in a home, they are re-homed to somewhere, and while there is a collection of research around relinquishment to shelters, little is known about the general re-homing picture. A cross sectional random digit dial survey was conducted with an aim to learn more about who is re-homing, where they are re-homing and why they are re-homing owned dogs and cats in the US. We found the prevalence of re-homing in five years at 6% making for an estimated 6.12 million household re-homing pets every five years. Pets were most likely to be re-homed by being given to a friend or family member (37%) closely followed by being taken to a shelter. Those who re-homed due to a reason related to the pet as opposed to reasons such as family issues were more likely to re-home to a shelter. For respondents who rented, housing reasons were the number one reason for re-homing, and for respondents of lower income, they were significantly more likely to re-home due to cost and housing issues as opposed to pet related issues. We conclude that some reasons for re-homing are not easily modified and humane re-homing is the best option, but that there are many areas in which intervention and prevention programs may increase retention.
文摘Background: Cimicoxib is a coxib recently licensed in Europe for pain and inflammation associated with osteoarthritis (OA), and the management of perioperative pain due to orthopaedic or soft tissue surgery. Purpose: This prospective study was to complete the product information for the end users by providing additional scientific data obtained after a thirty-day treatment course of cimicoxib in dogs with OA, and to collect owners’ feedback. Data were collected from nine European countries with 492 client owned dogs recruited to the trial. Dogs were treated once daily with 2 mg/kg cimicoxib orally. Immediately before, at Day (D) 15 and D30 after the start of treatment veterinarians and owners scored body condition, appetite, locomotion, lameness, pain on palpation and manipulation of the joint and joint effusion (veterinarians) and dog demeanor and well being (owners). In a subset of dogs, serum urea (n = 191), creatinine (n = 184), AST (n = 141) and ALT (n = 174) were measured at day (D) 0 and D30. Statistical tests were carried out to detect significant changes in the clinical parameters with time. Results and Discussion: Veterinary and owner assessments were analysed from 236 and 215 dogs respectively. Improvements in locomotion, mobility, pain scores and dog demeanor and body condition were identified;outcome measures assessed by veterinarians continued to improve after 15 days of treatment up to the 30-day time point. At D30 a significantly higher number of dogs had an urea concentration superior to the upper limit of the reference range. However, there was no significant difference for creatinine, ALT and AST. Conclusions: A 30-day treatment course with cimicoxib improved locomotion and decreased pain scores in dogs with OA, with minimal adverse effects. These data, support pre-clinical data in dogs receiving cimicoxib and are useful for veterinarians making decisions about which NSAID to administer to dogs that require pain management for OA.
